A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives

P Liu, G Chen, J Zhang - Molecules, 2022 - mdpi.com
Liposomes have been considered promising and versatile drug vesicles. Compared with
traditional drug delivery systems, liposomes exhibit better properties, including site …

Overcoming barriers by local drug delivery with liposomes

SG Antimisiaris, A Marazioti, M Kannavou… - Advanced drug delivery …, 2021 - Elsevier
Localized or topical administration of drugs may be considered as a potential approach for
overcoming the problems caused by the various biological barriers encountered in drug …

Recent advances in intranasal liposomes for drug, gene, and vaccine delivery

VA Duong, TTL Nguyen, HJ Maeng - Pharmaceutics, 2023 - mdpi.com
Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …

The use of TPGS in drug delivery systems to overcome biological barriers

MT Luiz, LD Di Filippo, RC Alves, VHS Araújo… - European Polymer …, 2021 - Elsevier
Nanotechnology has been applied in the medicine field to improve the treatment of a wide
range of diseases. However, to reach the nanomedicines delivery to desirable target tissue …

Poloxamer 407/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery

MA Grimaudo, S Pescina, C Padula, P Santi… - Molecular …, 2018 - ACS Publications
Cyclosporine is an immunosuppressant agent approved for the treatment of dry eye disease
and used off-label for other ocular pathologies. Its formulation and ocular bioavailability …

Lipid-based particles: versatile delivery systems for mucosal vaccination against infection

B Corthésy, G Bioley - Frontiers in immunology, 2018 - frontiersin.org
Vaccination is the process of administering immunogenic formulations in order to induce or
harness antigen (Ag)-specific antibody and T cell responses in order to protect against …

Development of nasal vaccines and the associated challenges

X Nian, J Zhang, S Huang, K Duan, X Li, X Yang - Pharmaceutics, 2022 - mdpi.com
Viruses, bacteria, fungi, and several other pathogenic microorganisms usually infect the host
via the surface cells of respiratory mucosa. Nasal vaccination could provide a strong …

TPGS decorated liposomes as multifunctional nano-delivery systems

MA Farooq, NL Trevaskis - Pharmaceutical Research, 2023 - Springer
Liposomes are sphere-shaped vesicles that can capture therapeutics either in the outer
phospholipid bilayer or inner aqueous core. Liposomes, especially when surface-modified …

Liposome-based vaccines for minimally or noninvasive administration: an update on current advancements

M Aroffu, ML Manca, JL Pedraz… - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction Vaccination requires innovation to provide effective protection. Traditional
vaccines have several drawbacks, which can be overcome with advanced technologies and …

Strategies for fighting pandemic virus infections: Integration of virology and drug delivery

T Nakamura, N Isoda, Y Sakoda… - Journal of Controlled …, 2022 - Elsevier
Respiratory viruses have sometimes resulted in worldwide pandemics, with the influenza
virus and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) being major …